RAPH OTC
Raphael Pharmaceutical Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +536.4%
3Y: +35.9%
$1.40
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Cash Flow Trends
Operating Cash Flow
-$532K
+55.8% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$532K
+55.8% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$211K
-263.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| — Operating Activities — | ||||
| Net Income | -$2M | -$3M | -$1M | -$2M |
| Depreciation & Amort. | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2M | $200K | $390K |
| Change in Working Capital | $206K | $309K | -$59K | $597K |
| Other Non-Cash Items | $0 | $0 | $0 | $0 |
| Operating Cash Flow | -$1M | -$759K | -$1M | -$532K |
| — Investing Activities — | ||||
| Capital Expenditures | $0 | -$2K | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$2K | $0 | $0 |
| — Financing Activities — | ||||
| Net Debt Issuance | $174K | $0 | $0 | $41K |
| Stock Repurchased | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Financing | $13K | $0 | $0 | $0 |
| Financing Cash Flow | $1M | $896K | $1M | $321K |
| Net Change in Cash | $58K | $135K | -$58K | -$211K |
| Cash End of Period | $153K | $288K | $230K | $19K |
| Free Cash Flow | -$1M | -$761K | -$1M | -$532K |